跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,029 条关于
“IDH-mutant anaplastic glioma”
全部
6,029
临床试验
4,429
药物
416
机构
31
资讯
1,153
8个月前
CATNON Trial Final Results Confirm Adjuvant Temozolomide Benefit in IDH-Mutant Anaplastic Glioma
去年
Eflornithine Plus Lomustine Improves Survival in IDH-Mutant Anaplastic Astrocytoma
去年
European Regulators Recommend Approval of Vorasidenib for IDH-Mutant Grade 2 Glioma
10个月前
Vorasidenib Demonstrates Sustained Long-Term Efficacy in IDH-Mutant Grade 2 Glioma
去年
Servier to Present Case for Novel IDH-Mutant Glioma Drug Vorasidenib at EMA Review
去年
FDA Approves Voranigo (Vorasidenib) as First Targeted Therapy for IDH-Mutant Glioma
2年前
FDA Approves Vorasidenib (Voranigo) for IDH-Mutant Grade 2 Glioma
去年
FDA Approves Voranigo: First Targeted Therapy for IDH-Mutant Glioma Brain Cancer
9个月前
FDA Grants Fast Track Designation to Zotiraciclib for IDH-Mutant Recurrent High-Grade Glioma
10个月前
Orbus Therapeutics Reports Positive Phase 3 STELLAR Trial Results for Eflornithine in Recurrent IDH-Mutant Astrocytoma
第 1 页，共 116 页
上一页
下一页
